| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e2817954cd008bcd609a4c4eb49050be |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-2821
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-948 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6896
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-4711 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01K67-027
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N63-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-63
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-62
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-04 |
| filingDate |
1998-07-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2006-07-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e01cd04891c95b9fb06f7588a9886dbc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_765b3ffdc11f70fc33d01d7f6c737f09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_efbdf25b5e5c5121f88c1ad00d71e89e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_993978c759f3efdcb696adedad040da6 |
| publicationDate |
2006-07-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-7078191-B1 |
| titleOfInvention |
Composition and method for the detection of diseases associated with amyloid-like fibril or protein aggregate formation |
| abstract |
The present invention relates to novel compositions useful for elucidating the onset or progress of diseases such as Huntington's disease, that are associated with the formation of fibrils or protein aggregates. Further, the present invention relates to methods for monitoring formation of fibrils or protein aggregates as well as to methods for identifying inhibitors of fibril or protein aggregate formation. Additionally, the invention relates to inhibitors of the formation of fibrils or protein aggregates identified by the method of the invention as well as to pharmaceutical compositions that include the inhibitors. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007238184-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011014605-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2012172453-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9938519-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9116088-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9513196-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8304185-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8313906-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010021910-A1 |
| priorityDate |
1997-08-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |